SCHEMBL31332072

CC[C@@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O

nearest known ligand 0.56

Predicted protein targets (top 10)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	6/20	0.56

▸	VIPR1	P32241	3/20	0.56

▸	VIPR2	P41587	5/20	0.55

▸	KISS1R	Q969F8	5/20	0.55

▸	SCTR	P47872	1/20	0.53

▸	RAMP3	O60896	1/20	0.53

▸	CALCR	P30988	1/20	0.53

▸	NPY1R	P25929	2/20	0.53

▸	NPY4R	P50391	2/20	0.53

▸	NPY5R	Q15761	2/20	0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29397427	0.93	KISS1R (0.57)	GLP1RVIPR1KISS1RSCTRRAMP3
SCHEMBL29854508	0.93	VIPR1 (0.62)	GLP1RVIPR1VIPR2KISS1R
SCHEMBL29720184	0.93	GLP1R (0.65)	GLP1RVIPR1SCTR
SCHEMBL16507837	0.92	NPY4R (0.57)	GLP1RKISS1RNPY1RNPY4RNPY5R
SCHEMBL29854541	0.91	VIPR2 (0.62)	GLP1RVIPR1VIPR2
SCHEMBL16508124	0.90	NPY4R (0.60)	GLP1RKISS1RSCTRNPY1RNPY4R
SCHEMBL29854592	0.89	GLP1R (0.57)	GLP1RVIPR1VIPR2KISS1RSCTR
SCHEMBL29430436	0.89	VIPR1 (0.70)	GLP1RVIPR1VIPR2
SCHEMBL29516852	0.89	VIPR1 (0.70)	GLP1RVIPR1VIPR2
SCHEMBL29854491	0.89	VIPR2 (0.63)	GLP1RVIPR1VIPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20240374689-A1	HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME	LONGEVITY BIOTECH, INC.	2024-11-14	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20240374689-A1	HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME	SCTR, GIPR, APLNR	GLP1R 13/4885VIPR1 67/4885VIPR2 150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.